-
Hematopoietic stem cell heterogeneity in non-human primates revealed by five-lineage output bias analysis
In January 2023, a study led by Professor Bing Liu from Fifth Medical Center, Medical Innovation Research Department, Chinese PLA General Hospital was published in the international academic journal ——Blood Science . The title of the study is “Hematopoietic stem cell heterogeneity in non-human primates revealed by five-lineage output bias analysis”. This study elucidates the…
-
Associate Professor Jingjie Zhao: Standardized Design and Implementation Using Recognized Endpoint Indicators to Provide High-Quality Evaluation for TCM Intervention in Metabolic-Associated Fatty Liver Disease Research
On May 18, 2024, the “25th National Academic Conference on Traditional Chinese Medicine for Hepatobiliary Diseases” was successfully held in Chongqing. The conference invited masters of Chinese medicine, academicians, nationally renowned TCM doctors, and leading experts in hepatology from both traditional Chinese and Western medicine to present academic reports. The focus was on hot and…
-
Chairman Interview丨Professor Chunjun Xu: A Holistic Approach to the Treatment of Primary Liver Cancer
Primary liver cancer is currently the 4th most common malignant tumor and the 2nd leading cause of cancer-related death in China, posing a serious threat to the life and health of the Chinese people. Traditional Chinese Medicine (TCM) has extensive clinical experience in treating primary liver cancer, using a syndrome differentiation approach at different stages…
-
Machine Learning Prognostic Model for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation
In January 2023, a study led by Professor Xiao Jun Huang from Peking University People’s Hospital was published in the international academic journal ——Blood Science . The title of the study is “Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation”. This study elucidates the machine learning…
-
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins
In July 2023, a study led by Professor Zhijian Xiao from Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published in the international academic journal ——Blood Science . The title of the study is “Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via…
-
EBMT Exclusive Interview | Professor Yanmin Zhao: Maintenance Treatment Strategies for FLT3-ITD Mutant AML Patients After Transplantation
FMS-like tyrosine kinase 3 (FLT3) mutations, particularly internal tandem duplication mutations (FLT3-ITD), are one of the significant factors affecting the prognosis of patients with acute myeloid leukemia (AML). Overcoming the challenge of relapse after transplantation in patients with FLT3-mutated AML remains a significant clinical hurdle. At the 50th European Bone Marrow Transplantation (EBMT) annual meeting,…
Connecting Medical Expertise through Media
